Cinclus Pharma Holding AB (CINPHA) Drug Pipeline
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Cinclus Pharma Holding AB (SE:CINPHA) have in its pipeline
Cinclus Pharma Holding AB SE:CINPHA is currently developing the following drugs: Linaprazan Glurate - High Dose, Linaprazan Glurate - Low Dose, Lansoprazole - Marketed Approved Dose, Drug Drug Interaction, Linaprazan Glurate 50 Mg Twice Daily, Linaprazan Glurate 50 Mg Once Daily, Lansoprazole 30 Mg Once Daily, Linaprazan Glurate 25 Mg Qd, Linaprazan Glurate 50 Mg Qd, Linaprazan Glurate 75 Mg Qd, Linaprazan Glurate 25 Mg Bid, Linaprazan Glurate 50 Mg Bid, Linaprazan Glurate 75 Mg Bid, Linaprazan Glurate, Drug Drug Interaction - Clarithromycin, Drug Drug Interaction - Midazolam, Linaprazan Glurate, Single Ascending Dose Of X842, Multiple Ascending Dose Of X842, Losec, Omeprazole. These drug candidates are in various stages of clinical development as the company works toward FDA approval.